Dolby Laboratories, Inc. (DLB) Files Form 4 Insider Selling : Kevin J Yeaman Sells 51,230 Shares

Dolby Laboratories, Inc. (DLB): Kevin J Yeaman , President and CEO of Dolby Laboratories, Inc. sold 51,230 shares on Apr 28, 2016. The Insider selling transaction was reported by the company on May 2, 2016 to the Securities and Exchange Commission. The shares were sold at $46.56 per share for a total value of $2,370,322.25 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 28, 2016, Dagmar Dolby (10% owner) sold 25,738 shares at $40.85 per share price.On Feb 4, 2016, N William Jr Jasper (director) sold 7,759 shares at $35.49 per share price.Also, On Feb 4, 2016, Nicholas Jr Donatiello (director) sold 3,880 shares at $35.50 per share price.On Feb 3, 2016, Kevin J Yeaman (President and CEO) sold 2,504 shares at $35.62 per share price.

Shares of Dolby Laboratories (DLB) ended Wednesday, Apr 27, 2016 session in red amid volatile trading. The shares closed down -0.18 points or -0.42% at $42.48 with 2,06,521 shares getting traded. Post opening the session at $42.56, the shares hit an intraday low of $42.168 and an intraday high of $42.64 and the price vacillated in this range throughout the day. The company has a market cap of $4,282 M and the number of outstanding shares has been calculated to be 10,07,96,058 shares. The 52-week high of Dolby Laboratories is $44.97 and the 52-week low is $29.87.

Dolby Laboratories Money Flow Index Chart

Company has been under the radar of several Street Analysts.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 54 from a previous price target of $46 .The Rating was issued on Apr 28, 2016.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 46 from a previous price target of $38 .The Rating was issued on Apr 25, 2016.Dolby Laboratories is Downgraded by JP Morgan to Neutral. Earlier the firm had a rating of Overweight on the company shares. The Rating was issued on Apr 8, 2016.Dolby Laboratories is Reiterated by Dougherty & Company to Buy and the brokerage firm has raised the Price Target to $ 46 from a previous price target of $38 .The Rating was issued on Mar 28, 2016.

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Leave a Reply

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.